Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Braftovi
Braftovi
Pfizer's Braftovi combo on track for full approval in win for FDA's Project FrontRunner
Fierce Pharma
Mon, 02/3/25 - 11:56 am
Pfizer
Braftovi
FDA
colorectal cancer
Bristol Myers, Pfizer tout new standards of care in colorectal cancer subtypes
Fierce Pharma
Sun, 01/26/25 - 04:11 pm
Bristol Myers Squibb
Pfizer
colorectal cancer
Opdivo
Yervoy
Braftovi
Pfizer's Braftovi to command 42% share of BRAF inhibitors melanoma market by 2028
Biopharma Reporter
Thu, 03/21/24 - 11:37 am
Pfizer
Braftovi
Roche
Zelboraf
melanoma
Pfizer, playing catch-up with Novartis, bags FDA approval for drug combo in lung cancer
Fierce Pharma
Thu, 10/12/23 - 11:34 am
Pfizer
Braftovi
Maktovi
metastatic non-small cell lung cancer
FDA
FDA Accepts SNDAs For Pfizer's Braftovi + Mektovi
NASDAQ
Wed, 04/5/23 - 10:18 am
Pfizer
FDA
Braftovi
Mektovi
metastatic non-small cell lung cancer
FDA Approves Pfizer's Braftovi Plus Cetuximab for Colorectal Cancer with BRAF Mutations
BioSpace
Thu, 04/9/20 - 11:34 pm
FDA
Pfizer
Braftovi
Erbitux
metastatic colorectal cancer
Exact Sciences Should Benefit from Pfizer’s News Today
Motley Fool
Thu, 12/19/19 - 12:05 am
Pfizer
colorectal cancer
EXACT Sciences
FDA
Braftovi
Cologuard
Array, Pierre Fabre bowel cancer therapy ‘could replace chemo’
Pharmaforum
Mon, 07/8/19 - 09:48 am
Braftovi
Array Biopharma
Pierre Fabre
Eli Lilly
Mektovi
Erbitux
colorectal cancer
clinical trials
Two years into dance, BEACON data clinched Pfizer-Array deal
BioCentury
Mon, 07/1/19 - 11:55 am
Pfizer
Array Biopharma
Braftovi
Mektovi
Array gets a win in colorectal cancer
Biopharma Dive
Tue, 05/21/19 - 11:01 pm
Array Biopharma
Braftovi
Mektovi
colorectal cancer
Here's Why Array BioPharma Jumped 31% in January
Motley Fool
Mon, 02/4/19 - 09:53 am
Array Biopharma
Eli Lilly
Braftovi
Mektovi
Array wrestles FDA OK for its MEK/BRAF melanoma combo, to hit the pharmacy as Mektovi and Braftovi
Endpoints
Wed, 06/27/18 - 09:44 pm
Array Biopharma
binimetinib
Mektovi
Braftovi
melanoma